Canopy Growth (CGC) Competitors

$1.14 +0.04 (+3.15%)

As of 01:54 PM Eastern

CGC vs. ACB, CRON, OGI, SNDL, and TLRY

Should you be buying Canopy Growth stock or one of its competitors? The main competitors of Canopy Growth include Aurora Cannabis (ACB), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). These companies are all part of the "pharmaceutical products" industry.

How does Canopy Growth compare to Aurora Cannabis?

Aurora Cannabis (NASDAQ:ACB) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, valuation and profitability.

In the previous week, Aurora Cannabis and Aurora Cannabis both had 4 articles in the media. Canopy Growth's average media sentiment score of 1.47 beat Aurora Cannabis' score of 0.45 indicating that Canopy Growth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aurora Cannabis	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Canopy Growth	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Canopy Growth	2 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

Aurora Cannabis has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500. Comparatively, Canopy Growth has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500.

47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 3.3% of Canopy Growth shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by company insiders. Comparatively, 0.2% of Canopy Growth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Aurora Cannabis has a net margin of -23.46% compared to Canopy Growth's net margin of -94.39%. Aurora Cannabis' return on equity of -0.04% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-23.46%	-0.04%	-0.03%
Canopy Growth	-94.39%	-46.85%	-28.95%

Aurora Cannabis has higher revenue and earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$373.12M	0.56	$1.63M	-$1.08	N/A
Canopy Growth	$225.65M	2.05	-$429.86M	-$1.30	N/A

Summary

Aurora Cannabis beats Canopy Growth on 7 of the 13 factors compared between the two stocks.

How does Canopy Growth compare to Cronos Group?

Canopy Growth (NASDAQ:CGC) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations, valuation and media sentiment.

Cronos Group has lower revenue, but higher earnings than Canopy Growth. Cronos Group is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$225.65M	2.05	-$429.86M	-$1.30	N/A
Cronos Group	$146.59M	6.99	-$9.45M	-$0.01	N/A

In the previous week, Cronos Group had 6 more articles in the media than Canopy Growth. MarketBeat recorded 10 mentions for Cronos Group and 4 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 1.47 beat Cronos Group's score of 0.63 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Canopy Growth	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cronos Group	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Canopy Growth has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500. Comparatively, Cronos Group has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500.

Cronos Group has a consensus target price of $2.30, indicating a potential downside of 15.60%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts plainly believe Cronos Group is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	2 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Cronos Group has a net margin of -6.44% compared to Canopy Growth's net margin of -94.39%. Cronos Group's return on equity of -1.12% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-94.39%	-46.85%	-28.95%
Cronos Group	-6.44%	-1.12%	-1.07%

3.3% of Canopy Growth shares are owned by institutional investors. Comparatively, 8.7% of Cronos Group shares are owned by institutional investors. 0.2% of Canopy Growth shares are owned by company insiders. Comparatively, 7.8% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Cronos Group beats Canopy Growth on 12 of the 15 factors compared between the two stocks.

How does Canopy Growth compare to Organigram Global?

Canopy Growth (NASDAQ:CGC) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, media sentiment and valuation.

3.3% of Canopy Growth shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 0.2% of Canopy Growth shares are owned by insiders. Comparatively, 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Organigram Global has a net margin of 6.03% compared to Canopy Growth's net margin of -94.39%. Organigram Global's return on equity of -15.41% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-94.39%	-46.85%	-28.95%
Organigram Global	6.03%	-15.41%	-10.49%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	2 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Canopy Growth and Canopy Growth both had 4 articles in the media. Canopy Growth's average media sentiment score of 1.47 beat Organigram Global's score of 0.33 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Canopy Growth	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Organigram Global	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Canopy Growth has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500. Comparatively, Organigram Global has a beta of 1.5, indicating that its share price is 50% more volatile than the S&P 500.

Organigram Global has higher revenue and earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$225.65M	2.05	-$429.86M	-$1.30	N/A
Organigram Global	$279.99M	0.68	-$17.70M	$0.14	9.61

Summary

Organigram Global beats Canopy Growth on 10 of the 13 factors compared between the two stocks.

How does Canopy Growth compare to SNDL?

SNDL (NASDAQ:SNDL) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, institutional ownership and profitability.

SNDL currently has a consensus target price of $5.00, suggesting a potential upside of 250.88%. Given SNDL's higher possible upside, equities analysts plainly believe SNDL is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SNDL	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67
Canopy Growth	2 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

SNDL has a net margin of -1.19% compared to Canopy Growth's net margin of -94.39%. SNDL's return on equity of -1.02% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SNDL	-1.19%	-1.02%	-0.85%
Canopy Growth	-94.39%	-46.85%	-28.95%

In the previous week, Canopy Growth had 1 more articles in the media than SNDL. MarketBeat recorded 4 mentions for Canopy Growth and 3 mentions for SNDL. Canopy Growth's average media sentiment score of 1.47 beat SNDL's score of -0.55 indicating that Canopy Growth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SNDL	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Negative
Canopy Growth	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

SNDL has higher revenue and earnings than Canopy Growth. SNDL is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SNDL	$677.32M	0.54	-$11.29M	-$0.03	N/A
Canopy Growth	$225.65M	2.05	-$429.86M	-$1.30	N/A

3.3% of Canopy Growth shares are held by institutional investors. 0.2% of Canopy Growth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

SNDL has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500. Comparatively, Canopy Growth has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500.

Summary

SNDL and Canopy Growth tied by winning 8 of the 16 factors compared between the two stocks.

How does Canopy Growth compare to Tilray Brands?

Tilray Brands (NASDAQ:TLRY) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

Canopy Growth has a net margin of -94.39% compared to Tilray Brands' net margin of -156.51%. Tilray Brands' return on equity of -3.31% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-156.51%	-3.31%	-2.42%
Canopy Growth	-94.39%	-46.85%	-28.95%

Tilray Brands presently has a consensus price target of $11.50, suggesting a potential upside of 105.25%. Given Tilray Brands' stronger consensus rating and higher possible upside, research analysts plainly believe Tilray Brands is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25
Canopy Growth	2 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Tilray Brands had 17 more articles in the media than Canopy Growth. MarketBeat recorded 21 mentions for Tilray Brands and 4 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 1.47 beat Tilray Brands' score of 0.92 indicating that Canopy Growth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tilray Brands	12 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Canopy Growth	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

9.4% of Tilray Brands shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 0.8% of Tilray Brands shares are owned by company insiders. Comparatively, 0.2% of Canopy Growth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Canopy Growth has higher revenue and earnings than Tilray Brands. Canopy Growth is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	$210.48M	3.10	-$2.19B	-$13.65	N/A
Canopy Growth	$225.65M	2.05	-$429.86M	-$1.30	N/A

Tilray Brands has a beta of 1.94, indicating that its share price is 94% more volatile than the S&P 500. Comparatively, Canopy Growth has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500.

Summary

Tilray Brands beats Canopy Growth on 11 of the 16 factors compared between the two stocks.

Get Canopy Growth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CGC vs. The Competition

Export

Metric	Canopy Growth	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$462.72M	$7.86B	$6.20B	$12.30B
Dividend Yield	N/A	2.50%	2.78%	5.22%
P/E Ratio	-0.88	16.53	20.68	25.76
Price / Sales	2.05	7.96	558.03	78.11
Price / Cash	N/A	17.15	27.81	36.27
Price / Book	0.60	3.48	9.82	6.78
Net Income	-$429.86M	$223.05M	$3.55B	$333.43M
7 Day Performance	N/A	N/A	N/A	0.49%
1 Month Performance	9.05%	38.83%	6.72%	9.25%
1 Year Performance	-13.26%	4.13%	42.70%	43.00%

Canopy Growth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CGC Canopy Growth	1.36 of 5 stars	$1.15 +3.2%	N/A	-15.9%	$462.72M	$225.65M	N/A	3,150	Positive News
ACB Aurora Cannabis	0.9212 of 5 stars	$3.42 -1.7%	N/A	-29.5%	$205.69M	$246.72M	N/A	1,130	Analyst Upgrade
CRON Cronos Group	1.0034 of 5 stars	$2.65 +0.4%	$2.30 -13.2%	+28.3%	$993.36M	$146.59M	N/A	450	News Coverage Positive News Earnings Report
OGI Organigram Global	1.2421 of 5 stars	$1.39 -2.1%	N/A	+15.3%	$199.89M	$185.07M	N/A	1,139	Analyst Downgrade
SNDL SNDL	2.7013 of 5 stars	$1.42 +0.7%	$5.00 +252.1%	+11.2%	$362.93M	$677.32M	N/A	2,751

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CGC) was last updated on 5/11/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canopy Growth (CGC) Competitors

CGC vs. ACB, CRON, OGI, SNDL, and TLRY

How does Canopy Growth compare to Aurora Cannabis?

Summary

How does Canopy Growth compare to Cronos Group?

Summary

How does Canopy Growth compare to Organigram Global?

Summary

How does Canopy Growth compare to SNDL?

Summary

How does Canopy Growth compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CGC vs. The Competition

Canopy Growth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Canopy Growth (CGC) Competitors

CGC vs. ACB, CRON, OGI, SNDL, and TLRY

How does Canopy Growth compare to Aurora Cannabis?

Does the media prefer ACB or CGC?

Do analysts prefer ACB or CGC?

Which has more risk & volatility, ACB or CGC?

Do institutionals & insiders believe in ACB or CGC?

Is ACB or CGC more profitable?

Which has stronger valuation & earnings, ACB or CGC?

Summary

How does Canopy Growth compare to Cronos Group?

Which has stronger earnings and valuation, CGC or CRON?

Does the media favor CGC or CRON?

Which has more risk & volatility, CGC or CRON?

Do analysts recommend CGC or CRON?

Is CGC or CRON more profitable?

Do insiders and institutionals believe in CGC or CRON?

Summary

How does Canopy Growth compare to Organigram Global?

Do institutionals and insiders believe in CGC or OGI?

Is CGC or OGI more profitable?

Do analysts recommend CGC or OGI?

Does the media refer more to CGC or OGI?

Which has more volatility and risk, CGC or OGI?

Which has higher earnings & valuation, CGC or OGI?

Summary

How does Canopy Growth compare to SNDL?

Do analysts rate SNDL or CGC?

Is SNDL or CGC more profitable?

Does the media prefer SNDL or CGC?

Which has better valuation and earnings, SNDL or CGC?

Do institutionals & insiders have more ownership in SNDL or CGC?

Which has more volatility and risk, SNDL or CGC?

Summary

How does Canopy Growth compare to Tilray Brands?

Is TLRY or CGC more profitable?

Do analysts rate TLRY or CGC?

Does the media refer more to TLRY or CGC?

Do institutionals and insiders hold more shares of TLRY or CGC?

Which has better earnings & valuation, TLRY or CGC?

Which has more volatility & risk, TLRY or CGC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CGC vs. The Competition

Canopy Growth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools